These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24285420)

  • 1. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
    Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
    Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.
    Göransson M; Elias E; Ståhlberg A; Olofsson A; Andersson C; Aman P
    Int J Cancer; 2005 Jul; 115(4):556-60. PubMed ID: 15688424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
    Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
    Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of FUS-CHOP fusion gene in paraffin-embedded tissues and its clinicopathologic significance for myxoid/round cell liposarcomas].
    Xiang H; Wang J; Sun MH; Lu L; Shui RH; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):28-32. PubMed ID: 15796878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
    Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
    Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
    Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
    Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
    Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
    Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.
    Tornin J; Hermida-Prado F; Padda RS; Gonzalez MV; Alvarez-Fernandez C; Rey V; Martinez-Cruzado L; Estupiñan O; Menendez ST; Fernandez-Nevado L; Astudillo A; Rodrigo JP; Lucien F; Kim Y; Leong HS; Garcia-Pedrero JM; Rodriguez R
    Neoplasia; 2018 Jan; 20(1):44-56. PubMed ID: 29190494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
    Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
    Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular diagnosis of liposarcomas: identification of the chimeric genes FUS/CHOP and EWS/CHOP].
    Kekeeva TV; Riazantseva AA; Anreeva IuIu; Zavalishina LE; Babenko OV; Zaletaev DV; Petrov AN; Frank GA
    Arkh Patol; 2009; 71(5):32-5. PubMed ID: 19938700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma.
    Borjigin N; Ohno S; Wu W; Tanaka M; Suzuki R; Fujita K; Takanashi M; Oikawa K; Goto T; Motoi T; Kosaka T; Yamamoto K; Kuroda M
    Biochem Biophys Res Commun; 2012 Oct; 427(2):355-60. PubMed ID: 22995304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
    Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis.
    Wu H; Xia L; Xu H
    Biochem Genet; 2022 Jun; 60(3):1095-1106. PubMed ID: 34792704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
    Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
    BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript.
    De Cecco L; Gariboldi M; Reid JF; Lagonigro MS; Tamborini E; Albertini V; Staurengo S; Pilotti S; Pierotti MA
    Histopathology; 2005 Mar; 46(3):334-41. PubMed ID: 15720420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
    Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
    Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.
    Pérez-Mancera PA; Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Flores T; Battaner E; Gutiérrez-Adán A; Pintado B; Sánchez-García I
    Oncogene; 2002 Mar; 21(11):1679-84. PubMed ID: 11896599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of fusion genes in adipocytic tumors.
    Kubo T; Matsui Y; Naka N; Araki N; Myoui A; Endo K; Yasui N; Ohtani O; Suzuki K; Kimura T; Yoshikawa H; Ueda T
    Anticancer Res; 2010 Feb; 30(2):661-4. PubMed ID: 20332486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model.
    Pérez-Mancera PA; Sánchez-García I
    Semin Cancer Biol; 2005 Jun; 15(3):206-14. PubMed ID: 15826835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.